Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0353
Source ID: NCT01087749
Associated Drug: Propranolol
Title: Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
Acronym: CKD
Status: COMPLETED
Study Results: NO
Results:
Conditions: Kidney Disease
Interventions: DRUG: Propranolol|DRUG: Losartan|DRUG: Eprosartan
Outcome Measures: Primary: Pharmacokinetic parameters, Three 12-hour days visits (on different weeks) will be investigated to obtain blood samples for 12 hours for three different medications. Blood samples will be obtained to determine the medication concentration in the plasma. There is no therapeutic effect on this study, since patients will receive a low single dose of the medication, and we'll assess the different pharmacokinetic parameters based on the concentrations of the medicine in plasma., 3 weeks |
Sponsor/Collaborators: Sponsor: University of California, San Francisco
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE1
Enrollment: 24
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
Start Date: 2010-03
Completion Date: 2012-12
Results First Posted:
Last Update Posted: 2013-05-30
Locations: Clinical Reserach Center, UCSF, San Francisco,, California, 94143, United States
URL: https://clinicaltrials.gov/show/NCT01087749